http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111635407-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111635407-B |
| titleOfInvention | Synthesis process of PARP inhibitor fluxaparide intermediate |
| abstract | The invention discloses a process method suitable for preparing 2-trifluoromethyl [1,2,4] triazolo [1,5-a ] pyrazine in an amplification way, belonging to the field of synthesis of pharmaceutical intermediates. The 2-aminopyrazine and ethyl trifluoroacetate are used as raw materials, and the 2-trifluoromethyl [1,2,4] triazolo [1,5-a ] pyrazine is obtained through urethane exchange reaction, substitution reaction and dehydration reaction. |
| priorityDate | 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.